AI-engineered nasal spray antiviral platform developed to block flu and COVID-19

Respiratory viruses that have diverse strains and mutate rapidly, such as influenza and COVID-19, are difficult to block perfectly with vaccines alone. To solve this problem, KAIST’s research team has successfully developed an intranasal…

Continue Reading

News Source: medicalxpress.com